|
Letture consigliate
553
Mignarri A., Malandrini A., Del Puppo M., Monti L.,
Ginanneschi F., Tessa A., Santorelli F.M., Federico
A., Dotti M.T. Hereditary spastic paraplegia type 5:
a potentially treatable disorder of cholesterol metabo-
lism.
J. Neurol.
2014; 261(3):617-619.
Salinas S., Proukakis C., Crosby A., Warner T.T. Hered-
itary spastic paraplegia: clinical features and pathoge-
netic mechanisms.
Lancet Neurol.
2008; 7:1127-1138.
Schule R., Schols L. Genetics of Hereditary Spastic
Paraplegias.
Semin. Neurol.
2011; 31(5):484-493.
Smith B.N., Bevan S., Vance C., Renwick P., Wilkinson
P., Proukakis C., Squitieri F., Berardelli A., Warner
T.T., Reid E., Shaw C.E. Four novel SPG3A/atlastin
mutations identified in autosomal dominant hered-
itary spastic paraplegia kindreds with intra-familial
variability in age of onset and complex phenotype.
Clin. Genet.
2009; 75(5):485-489.
Stevanin G., Azzedine H., Denora P., Boukhris
A., Tazir M., Lossos A., Rosa A.L., Lerer I., Ham-
ri A., Alegria P., Loureiro J., Tada M., Hannequin
D., Anheim M., Goizet C.,Gonzalez-Martinez V., Le
Ber I., Forlani S., Iwabuchi K., Meiner V., Uyan-
ik G., Erichsen A.K., Feki I., Pasquier F., Belarbi
S., Cruz V.T., Depienne C., Truchetto J., Garrigues
G., Tallaksen C., Tranchant C., Nishizawa M., Vale
J., Coutinho P., Santorelli F.M., Mhiri C., Brice
A., Durr A., SPATAX consortium. Mutations on
SPG11 are frequent in autosomal recessive spastic
paraplegia with thin corpus callosum, cognitive de-
cline and lower motor neuron degeneration.
Brain
2008; 131:772-784.
Si veda anche la sezione
Video consigliati
alla fine del
libro.
